Bilix Co.,Ltd.: Clinical Trials

2 trials sponsored by Bilix Co.,Ltd., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Recruiting 1

Follow Bilix Co.,Ltd.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Efficacy and Safety of BX-001N in Preventing Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI) and Major Adverse Kidney Events (MAKE)
BX-001N Experimental group 1, BX-001N Experimental group 2, Placebo group 1 - Ischemia Reperfusion Injury, Cardiac Surgery Associated - Acute Kidney Injury
Phase 2RecruitingBilix Co.,Ltd.502025-08-262026-07-01
A Study to Evaluate the Safety and Pharmacokinetics of BX-001N in Healthy Participants
BX-001N Part 1, BX-001N Part 2, Placebo - Ischemia-reperfusion Injury
Phase 1CompletedBilix Co.,Ltd.512023-11-172025-04-17

Conditions studied

Reperfusion Injury (2)

Countries

Australia (1)  ·  South Korea (1)

Top investigators

Angela C Rowland, Dr (1)  ·  Myung Lip Kim, Chief Executive Officer (1)